Cure Alzheimer's Fund Cure Alzheimer's Fund

Evaluating TMEM106B Accumulation in Alzheimer’s Disease

2022, 2023

Recent studies investigating a new type of filament found in patients with Alzheimer’s disease and related disorders identified TMEM106B, a protein normally localized to the lysosome, as the protein constituent. The current project is focused on developing new tools to label TMEM106B, and to understand the significance of TMEM106B filament accumulation and its relationship to the disease course.

Casey Cook Leonard Petrucelli Studies of Alternative Neurodegenerative Pathways Translational

Funding to Date

$402,500

Focus

Studies of Alternative Neurodegenerative Pathways, Translational

Researchers

Leonard Petrucelli, Ph.D.

Casey Cook, Ph.D.

Related Content:


Deciphering and Restoring Computational Setpoints in Alzheimer’s Disease Through Sleep-Enhanced Network Homeostasis Keith Hengen 2024-01-12 Morphological, Electrophysiological and Transcriptional Characterization of Single Neurons from Resilient and Susceptible Models of Human Alzheimer’s Disease Catherine Kaczorowski Shannon Moore 2024-01-10 Neuronal Mechanisms Driving Synapse Loss in Alzheimer’s Disease Martin Kampmann 2024-01-10 A Multimodality Study on the Lipid Molecular Basis of Obesity and Its Roles in Regulating Alzheimer’s Pathogenesis for Developing Potential Targeted Interventions Stephen T.C. Wong 2024-01-10 Restore Meningeal Lymphatic Drainage to Alleviate White Matter Damage and Cerebral Amyloid Angiopathy in a Model of Alzheimer’s Disease Sandro Da Mesquita 2023-12-09 Circadian Desynchrony, Glial Dysfunction and Alzheimer’s Disease Pathogenesis Erik S. Musiek 2023-12-09 Oligodendroglial Dynamics and Myelination in Alzheimer’s Disease Erin M. Gibson 2023-12-08 Scaling the Divide in Alzheimer’s Disease: An Integrated Molecular, Cellular and Network-Level Study Marc Aurel Busche Samuel Harris 2023-12-08